$20.95
1.608.27%
In chiusura: Nov 26, 4:00 PM EST
$21.00
0.050.24%
After hour: 7:58 PM EST
Comments
Loading...
Stime degli utili, EPS e fatturato
Sarepta Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
feb 25
Stima EPS
$-0.870
Stima dei ricavi trimestrali
$383.70M
Ricavi annuali
(a partire da set 30)
(a partire da set 30)
$2.41B
Analizza lo storico degli utili di Sarepta Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
SRPT | Sarepta Therapeutics | $1.90 | -$0.87 | — | — | $658.41M | $383.70M | — | — | 02/25/2026 | |
SRPT | Sarepta Therapeutics | $0.64 | -$0.46 | -$0.13 | 71.74% | $467.17M | $343.25M | $399.36M | 16.34% | 11/03/2025 | |
SRPT | Sarepta Therapeutics | $0.43 | $1.01 | $2.02 | 100.00% | $362.93M | $530.44M | $611.09M | 15.20% | 08/06/2025 | |
SRPT | Sarepta Therapeutics | $0.72 | -$0.65 | -$3.42 | -426.15% | $413.46M | $684.12M | $744.86M | 8.88% | 05/06/2025 | |
SRPT | Sarepta Therapeutics | $0.82 | $1.90 | $1.90 | 0.00% | $396.78M | $627.58M | $658.41M | 4.91% | 02/26/2025 | |
SRPT | Sarepta Therapeutics | $0.31 | $0.37 | $0.62 | 67.57% | $331.82M | $409.30M | $467.17M | 14.14% | 11/06/2024 | |
SRPT | Sarepta Therapeutics | -$0.85 | $0.02 | $0.44 | 2100.00% | $261.24M | $396.26M | $362.93M | -8.41% | 08/07/2024 | |
SRPT | Sarepta Therapeutics | -$0.99 | -$0.07 | $0.73 | 1142.86% | $253.50M | $373.28M | $413.46M | 10.77% | 05/01/2024 | |
SRPT | Sarepta Therapeutics | -$0.53 | $0.01 | $0.82 | 8100.00% | $258.43M | $385.81M | $396.78M | 2.84% | 02/28/2024 | |
SRPT | Sarepta Therapeutics | -$0.80 | -$1.32 | $0.37 | 128.03% | $230.27M | $288.50M | $331.82M | 15.01% | 11/01/2023 | |
SRPT | Sarepta Therapeutics | -$1.18 | -$1.89 | -$0.85 | 55.03% | $233.49M | $264.45M | $261.24M | -1.21% | 08/02/2023 | |
SRPT | Sarepta Therapeutics | -$0.56 | -$1.38 | -$0.97 | 29.71% | $210.83M | $241.96M | $253.50M | 4.77% | 05/02/2023 | |
SRPT | Sarepta Therapeutics | -$0.77 | -$1.35 | -$0.53 | 60.74% | $201.46M | $248.34M | $258.43M | 4.06% | 02/28/2023 | |
SRPT | Sarepta Therapeutics | -$0.19 | -$1.43 | -$0.80 | 44.06% | $189.41M | $234.52M | $230.27M | -1.81% | 11/02/2022 | |
SRPT | Sarepta Therapeutics | -$1.52 | -$1.18 | -$1.18 | 0.00% | $164.09M | $220.81M | $233.49M | 5.74% | 08/02/2022 | |
SRPT | Sarepta Therapeutics | -$1.54 | -$1.27 | -$0.56 | 55.91% | $146.93M | $206.44M | $210.83M | 2.13% | 05/04/2022 | |
SRPT | Sarepta Therapeutics | -$1.84 | -$1.13 | -$0.77 | 31.86% | $145.14M | $198.61M | $201.46M | 1.44% | 03/01/2022 | |
SRPT | Sarepta Therapeutics | -$1.42 | -$1.89 | -$0.19 | 89.95% | $143.92M | $173.42M | $189.41M | 9.22% | 11/03/2021 | |
SRPT | Sarepta Therapeutics | -$1.51 | -$1.29 | -$1.52 | -17.83% | $137.36M | $162.64M | $164.09M | 0.89% | 08/04/2021 | |
SRPT | Sarepta Therapeutics | -$1.04 | -$1.78 | -$1.54 | 13.48% | $113.67M | $143.33M | $146.93M | 2.51% | 05/05/2021 | |
SRPT | Sarepta Therapeutics | -$1.57 | -$1.77 | -$1.84 | -3.95% | $100.11M | $146.29M | $145.14M | -0.79% | 03/01/2021 |
Sarepta Therapeutics (SRPT) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $-0.13 | $-0.46 | 71.7 % |
| Q2 | 2025-08-06 | $2.02 | $1.01 | 100.0 % |
| Q1 | 2025-05-06 | $-3.42 | $-0.65 | -426.1 % |
| Q4 | 2025-02-26 | $1.90 | $1.90 | 0.00 % |
Sarepta Therapeutics (SRPT) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $399.36M | $343.25M | 16.3 % |
| Q2 | 2025-08-06 | $611.09M | $530.44M | 15.2 % |
| Q1 | 2025-05-06 | $744.86M | $684.12M | 8.88 % |
| Q4 | 2025-02-26 | $658.41M | $627.58M | 4.91 % |
FAQ
Quando Sarepta Therapeutics (NASDAQ:SRPT) riporterà gli utili?
Si prevede che Sarepta Therapeutics (SRPT) fornisca risultati il febbraio 25, 2026. Gli ultimi risultati sono stati pubblicati il novembre 3, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Sarepta Therapeutics (NASDAQ:SRPT)?
L'EPS effettivo era $-0.13, che superato la stima di $-0.46.
Quali sono state le entrate di Sarepta Therapeutics (NASDAQ:SRPT)?
Le entrate effettive sono state $399.4M, che superato la stima di $343.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.